Teva Pharmaceuticals has agreed to pay $27 million to settle federal and state accusation of false claims regarding the antipsychotic Clozapine, and payments made to an Illinois physician to under a “consulting contract.” “Pharmaceutical companies must not be allowed to improperly influence physicians’ decisions in prescribing medication for their patients,” said the U.S. Attorney for the Northern District of Illinois.
Teva to Pay $27.6 Million to Settle Improper Payment Allegations (Wall Street Journal)
Teva agrees to pay $27.6 million to resolve US improper payment allegations (First Word Pharma)
Teva to Pay $27.6 Million to Settle Improper Payment Allegations NASDAQ.com
Pharmaceutical Company to Pay $27.6 Million to Settle Allegations Involving False Billings to Federal Health Care Programs (eNews Park Forest)